Suzhou Oriental Semiconductor Co Ltd
SSE:688261
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Suzhou Oriental Semiconductor Co Ltd
SSE:688261
|
CN |
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
CN |
Income Statement
Earnings Waterfall
Suzhou Oriental Semiconductor Co Ltd
Income Statement
Suzhou Oriental Semiconductor Co Ltd
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
380
N/A
|
529
+39%
|
782
+48%
|
846
+8%
|
928
+10%
|
1 013
+9%
|
1 116
+10%
|
1 213
+9%
|
1 183
-2%
|
1 096
-7%
|
973
-11%
|
844
-13%
|
859
+2%
|
883
+3%
|
1 003
+14%
|
1 113
+11%
|
1 200
+8%
|
1 286
+7%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(295)
|
(385)
|
(559)
|
(595)
|
(635)
|
(685)
|
(740)
|
(806)
|
(817)
|
(796)
|
(760)
|
(701)
|
(728)
|
(747)
|
(882)
|
(953)
|
(1 016)
|
(1 090)
|
|
| Gross Profit |
85
N/A
|
144
+69%
|
223
+55%
|
252
+13%
|
293
+16%
|
328
+12%
|
376
+15%
|
407
+8%
|
367
-10%
|
300
-18%
|
213
-29%
|
142
-33%
|
131
-8%
|
136
+4%
|
121
-11%
|
160
+32%
|
183
+15%
|
196
+7%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(27)
|
(43)
|
(61)
|
(61)
|
(69)
|
(68)
|
(83)
|
(93)
|
(101)
|
(106)
|
(103)
|
(113)
|
(126)
|
(140)
|
(127)
|
(164)
|
(174)
|
(179)
|
|
| Selling, General & Administrative |
(13)
|
(19)
|
(25)
|
(24)
|
(28)
|
(28)
|
(37)
|
(37)
|
(36)
|
(37)
|
(28)
|
(30)
|
(38)
|
(46)
|
(51)
|
(71)
|
(74)
|
(75)
|
|
| Research & Development |
(20)
|
(28)
|
(40)
|
(42)
|
(45)
|
(48)
|
(53)
|
(66)
|
(74)
|
(79)
|
(81)
|
(86)
|
(84)
|
(80)
|
(70)
|
(76)
|
(79)
|
(86)
|
|
| Depreciation & Amortization |
0
|
(1)
|
(4)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
7
|
6
|
8
|
6
|
5
|
9
|
12
|
10
|
8
|
9
|
13
|
3
|
(3)
|
(14)
|
8
|
(18)
|
(21)
|
(18)
|
|
| Operating Income |
59
N/A
|
101
+72%
|
163
+61%
|
191
+17%
|
224
+17%
|
260
+16%
|
293
+12%
|
314
+7%
|
265
-15%
|
194
-27%
|
110
-44%
|
30
-73%
|
5
-82%
|
(4)
N/A
|
(6)
-51%
|
(4)
+30%
|
9
N/A
|
17
+85%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
5
|
5
|
6
|
7
|
14
|
22
|
34
|
38
|
39
|
45
|
41
|
42
|
45
|
36
|
39
|
38
|
34
|
33
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Other Income |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
|
| Pre-Tax Income |
63
N/A
|
106
+67%
|
169
+60%
|
198
+17%
|
239
+21%
|
283
+19%
|
327
+16%
|
352
+8%
|
304
-14%
|
239
-21%
|
150
-37%
|
71
-52%
|
50
-29%
|
32
-36%
|
33
+2%
|
34
+3%
|
44
+28%
|
52
+19%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(13)
|
(21)
|
(22)
|
(24)
|
(27)
|
(29)
|
(43)
|
(45)
|
(36)
|
(23)
|
(10)
|
2
|
6
|
7
|
7
|
7
|
2
|
(1)
|
|
| Income from Continuing Operations |
51
|
84
|
147
|
174
|
212
|
254
|
284
|
308
|
268
|
216
|
140
|
73
|
57
|
39
|
40
|
41
|
45
|
50
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
8
|
|
| Net Income (Common) |
51
N/A
|
84
+66%
|
147
+74%
|
174
+18%
|
212
+22%
|
254
+20%
|
284
+12%
|
308
+8%
|
268
-13%
|
216
-19%
|
140
-35%
|
73
-48%
|
57
-22%
|
39
-31%
|
40
+3%
|
44
+9%
|
51
+16%
|
58
+14%
|
|
| EPS (Diluted) |
1.5
N/A
|
1.25
-17%
|
1.6
+28%
|
2.58
+61%
|
3.14
+22%
|
2.92
-7%
|
2.32
-21%
|
3.26
+41%
|
2.83
-13%
|
2.29
-19%
|
1.14
-50%
|
0.65
-43%
|
0.42
-35%
|
0.33
-21%
|
0.33
N/A
|
0.35
+6%
|
0.41
+17%
|
0.47
+15%
|
|